Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Rubius Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2022
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
- Summary
-
Rubius Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 31 Mar 2019 to 31 Dec 2022.
- Rubius Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2022 was $0, a 100% decline year-over-year.
- Source SEC data
- View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)
Rubius Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -$8,815,000 | -100% | 31 Dec 2022 | 10-K | 27 Feb 2023 | 2022 | FY |
| Q4 2021 | $8,815,000 | -$2,887,000 | -25% | 31 Dec 2021 | 10-K | 25 Feb 2022 | 2021 | FY |
| Q4 2020 | $11,702,000 | -$3,240,000 | -22% | 31 Dec 2020 | 10-K | 23 Feb 2021 | 2020 | FY |
| Q4 2019 | $14,942,000 | 31 Dec 2019 | 10-K | 12 Mar 2020 | 2019 | FY | ||
| Q3 2019 | $15,857,000 | 30 Sep 2019 | 10-Q | 14 Nov 2019 | 2019 | Q3 | ||
| Q2 2019 | $8,708,000 | 30 Jun 2019 | 10-Q | 13 Aug 2019 | 2019 | Q2 | ||
| Q1 2019 | $9,253,000 | 31 Mar 2019 | 10-Q | 15 May 2019 | 2019 | Q1 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.